Literature DB >> 7803291

Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia.

P Ljungman1, M Lawler, B Asjö, G Bogdanovic, K Karlsson, C Malm, S R McCann, O Ringdén, G Gahrton.   

Abstract

Human T lymphotrophic virus type 1 (HTLV-I) associated leukaemia has a poor prognosis even with chemotherapy. We describe a patient with adult T-cell leukaemia treated with allogeneic bone marrow transplantation from an HTLV-I negative identical sibling donor. During follow-up after bone marrow transplantation, HTLV-I could be repeatedly isolated inspite of anti-viral prophylaxis. The patient died of an acute encephalitis and HTLV-I could be detected in autopsy material from the brain. By a PCR-based technique using short tandem repeats (STRs) it was shown that the patient's haemopoiesis was of donor origin. This shows the infection of donor cells in vivo by an aetiological agent which has been implicated in the leukaemogenic process for adult T-cell leukaemia.

Entities:  

Mesh:

Year:  1994        PMID: 7803291     DOI: 10.1111/j.1365-2141.1994.tb05040.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.

Authors:  R N Lown; J Philippe; W Navarro; S M van Walraven; L Philips-Johnson; M Fechter; R Pawson; M Bengtsson; M Beksac; S Field; H Yang; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-04-07       Impact factor: 5.483

2.  Clinical efficacy of all-trans retinoic acid for treating adult T cell leukemia.

Authors:  Yasuhiro Maeda; Terufumi Yamaguchi; Yasuki Hijikata; Miyako Tanaka; Chikara Hirase; Shunsuke Takai; Yasuyoshi Morita; Tetsuaki Sano; Jun-Ichi Miyatake; Yoichi Tatsumi; Akihisa Kanamaru
Journal:  J Cancer Res Clin Oncol       Date:  2007-11-15       Impact factor: 4.553

Review 3.  Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?

Authors:  E H Phillips; A Hodson; O Hermine; A Bazarbachi; K Cwynarski
Journal:  Bone Marrow Transplant       Date:  2016-09-12       Impact factor: 5.483

4.  Single-dose daily infusion of cyclosporine for prevention of Graft-versus-host disease after allogeneic bone marrow transplantation from HLA allele-matched, unrelated donors.

Authors:  Yuichiro Nawa; Masamichi Hara; Kazushi Tanimoto; Koichi Nakase; Teruhiko Kozuka; Yoshinobu Maeda
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

5.  Transmission of Human T-Lymphotropic Virus Type I to Donor-Origin T Cells During Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Makoto Hirosawa; Daisuke Niino; Junichi Tsukada
Journal:  J Hematol       Date:  2022-03-12

Review 6.  Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma.

Authors:  Atae Utsunomiya
Journal:  Front Microbiol       Date:  2019-10-01       Impact factor: 5.640

Review 7.  Human T-cell lymphotropic-I-associated leukemia/lymphoma.

Authors:  R S Siegel; R B Gartenhaus; T M Kuzel
Journal:  Curr Treat Options Oncol       Date:  2001-08

Review 8.  Current status of therapeutic approaches to adult T-cell leukemia.

Authors:  Takayuki Ishikawa
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.319

Review 9.  An Update on the Progress of Isolation, Culture, Storage, and Clinical Application of Human Bone Marrow Mesenchymal Stem/Stromal Cells.

Authors:  Dinh-Toi Chu; Thuy Nguyen Thi Phuong; Nguyen Le Bao Tien; Dang Khoa Tran; Vo Van Thanh; Thuy Luu Quang; Dang Tien Truong; Van Huy Pham; Vo Truong Nhu Ngoc; Thien Chu-Dinh; Kushi Kushekhar
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.